Introduction
Primary dysmenorrhea is one of the most frequently reported gynecological complaints, affecting nearly 50% of post-pubertal females. Contemporary biomedical understanding attributes its pathogenesis primarily to elevated prostaglandin F2-alpha (PGF2α), a potent uterotonic and vasoconstrictive mediator released from the secretory endometrium, leading to uterine hypercontractility, ischemia, and pain. In Ayurveda, this condition closely resembles Udavartini Yonivyapad, wherein aggravated Apana Vata moves in a reverse direction due to suppression of natural urges (vegavarodha), resulting in upward displacement of menstrual blood and severe colicky pain relieved after menstruation begins. Therapeutic management is therefore centered on Vata pacification and restoration of normal Apana Vayu flow.
Rationale of Uttara Vasti in Dysmenorrhea
Uttara Vasti is a specialized Ayurvedic para-surgical procedure involving intrauterine or intravaginal administration of medicated oils or decoctions. It is considered highly effective in disorders of the reproductive tract due to its direct local action on Apana Vata and pelvic structures. In primary dysmenorrhea, the therapeutic objective is to reduce uterine spasm, improve pelvic circulation, and normalize menstrual flow, which aligns with the pharmacological and Ayurvedic actions of the selected drugs-Lasuna (Allium sativum) oil and Trivrit (Operculina turpethum)-based formulations, often administered in a sesame oil base.
Pharmacological basis of Lasuna and Trivrit
- Lasuna (garlic) possesses katu and tikta rasa, along with snigdha, guru, and picchila guna, making it particularly effective in pacifying aggravated Vata. Pharmacologically, Lasuna exhibits anti-inflammatory, antispasmodic, and emmenagogue properties. It is known to inhibit prostaglandin synthesis, thereby reducing myometrial hyperactivity and relieving ischemic uterine pain. Additionally, its vasodilatory effects improve pelvic blood flow and facilitate smoother menstrual discharge.
- Trivrit (Operculina turpethum) is a potent laxative with vatanulomaka (downward regulation of Vata) and sukha rechaka (mild purgative) properties. It helps restore physiological directionality of Apana Vata, which is central to correcting the pathogenesis of Udavartini. By promoting elimination and reducing Vata obstruction, Trivrit supports systemic and pelvic channel clearance, indirectly reducing dysmenorrheic pain.
- Sesame oil (Tila taila), commonly used as the base medium, enhances drug delivery due to its snigdha and yogavahi properties and is considered one of the best Vata-shamaka oils in Ayurveda.
Mechanistic interpretation
The therapeutic effect of Uttara Vasti can be attributed to a combination of prostaglandin inhibition, uterine smooth muscle relaxation, and restoration of normal Apana Vata flow. Lasuna reduces inflammatory mediators responsible for uterine contractions, while Trivrit facilitates downward movement of Vata, correcting functional obstruction. Together, they act synergistically to reduce pain, improve menstrual flow, and restore pelvic homeostasis.
Conclusion
Uttara Vasti therapy using Lasuna and Trivrit oil represents a targeted Ayurvedic approach for managing primary dysmenorrhea by addressing both the physiological and energetic components of disease. Its combined anti-inflammatory, antispasmodic, and Vata-regulating actions offer effective symptom relief with minimal adverse effects. These findings support its potential as a safe and effective adjunct in the management of Udavartini Yonivyapad, warranting further large-scale clinical validation.1
References:
- Jahan S, Sujatha N, Neelam. Role of Uttara Vasti with Trivrit and Lasuna oil in the management of primary dysmenorrhea. Ayu. 2010;31(2):228-231. doi:10.4103/0974-8520.72405 https://pmc.ncbi.nlm.nih.gov/articles/PMC3215369/#sec1-4